Sequana Medical NV
XBRU:SEQUA
Sequana Medical NV
XBRU:SEQUA
Price:
0.611
EUR
Market Closed
Market Cap:
€47.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sequana Medical NV
XBRU:SEQUA
|
BE |
|
G
|
Greencoat Renewables PLC
ISEQ:GRP
|
IE |
|
Lamar Advertising Co
NASDAQ:LAMR
|
US |
|
Cigna Corp
NYSE:CI
|
US |
|
Electronic Arts Inc
NASDAQ:EA
|
US |
|
Lattice Semiconductor Corp
NASDAQ:LSCC
|
US |
|
Toshiba Corp
TSE:6502
|
JP |
|
S
|
Somboon Advance Technology PCL
SET:SAT
|
TH |
|
Truist Financial Corp
NYSE:TFC
|
US |
|
Alamtri Resources Indonesia Tbk PT
F:A640
|
ID |
|
M
|
Mon Courtier Energie SAS
PAR:ALMCE
|
FR |
|
JCDecaux SE
PAR:DEC
|
FR |
|
Silicon Motion Technology Corp
NASDAQ:SIMO
|
TW |
Wall St Price Targets
SEQUA Price Targets Summary
Sequana Medical NV
Sequana Medical NV
Wall Street analysts forecast SEQUA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for SEQUA is 2.142 EUR with a low forecast of 1.515 EUR and a high forecast of 2.835 EUR.
Lowest Forecast
Price Target
1.515
EUR
148% Upside
Average Forecast
Price Target
2.142
EUR
251% Upside
Highest Forecast
Price Target
2.835
EUR
364% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SEQUA's stock price target?
Price Target
2.142
EUR
2.142
EUR
According to Wall Street analysts, the average 1-year price target for SEQUA is 2.142 EUR with a low forecast of 1.515 EUR and a high forecast of 2.835 EUR.
What is the Revenue forecast for Sequana Medical NV?
Projected CAGR
462%
462%
Over the last 8 years, the compound annual growth rate for Revenue has been -28%. The projected CAGR for the next 3 years is 462%.
